During the past decade, Investigational Products Center (IPC) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 12 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Investigational Products Center (IPC)" #1 sponsor was "Pfizer" with 9 trials, followed by "Amgen" with 2 trials sponsored, "Point Therapeutics" with 2 trials sponsored, "Seagen Inc." with 2 trials sponsored and "University of Kansas Medical Center" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Investigational Products Center (IPC)" #1 collaborator was "Medivation, Inc." with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Investigational Products Center (IPC)" are "Breast Cancer" (4 trials), "Breast Neoplasms" (2 trials), "Kidney Neoplasms" (2 trials), "Lung Cancer" (2 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Investigational Products Center (IPC)" in a lesser frequency.

Most popular intervention types in "Investigational Products Center (IPC)" are "Drug" (20 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Axitinib (AG-013736)" (2 trials), "Sorafenib" (2 trials), "AMG 404" (1 trials) and "Alclometasone cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Investigational Products Center (IPC)" are 14 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Investigational Products Center (IPC)". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Investigational Products Center (IPC), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Investigational Products Center (IPC), 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".